Clinical Trial Update: Study of MP0112 Intravitreal Injection in Patients With Wet Age Related Macular Degeneration [Phase 1]

View source ↗

Summary

Allergan's Phase 1 trial of MP0112 given by intravitreal injection for wet age-related macular degeneration was terminated; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wet Age-related Macular Degeneration

Drugs mentioned

• MP0112

Snippet

Sponsor: Allergan | Conditions: Wet Age-Related Macular Degeneration | Phase 1 | Status: TERMINATED | Results posted: 2014-05-12